As of March 2024 Codexis has a market cap of $0.24 Billion. This makes Codexis the world's 6761th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $0.24 B | 15.2% |
2023 | $0.21 B | -30.42% |
2022 | $0.30 B | -84.91% |
2021 | $2.02 B | 46.19% |
2020 | $1.38 B | 47.4% |
2019 | $0.94 B | 4.27% |
2018 | $0.90 B | 123.65% |
2017 | $0.40 B | 112.91% |
2016 | $0.18 B | 11.11% |
2015 | $0.17 B | 71.17% |
2014 | $99.69 M | 85.69% |
2013 | $53.69 M | -35.54% |
2012 | $83.29 M | -56.28% |
2011 | $0.19 B | -48.39% |
2010 | $0.36 B |
On Mar 28th, 2024 the market cap of Codexis was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
Pfizer PFE | $157.13 B | 63,942.94% | ๐บ๐ธ USA |
Merck MRK | $334.18 B | 136,100.85% | ๐บ๐ธ USA |
Dupont De Nemours DD | $32.01 B | 12,948.64% | ๐บ๐ธ USA |
Balchem BCPC | $4.99 B | 1,937.73% | ๐บ๐ธ USA |